NCT05097001

Brief Summary

The primary objective of this exploratory study is to prospectively evaluate the feasibility of image-guided programming of pallidal deep brain stimulation (DBS) for dystonia. The dystonias are a heterogeneous group of movement disorders that share the core clinical feature of abnormal involuntary muscle contractions in common. Pallidal DBS is an established therapy for severe cases with an average improvement in dystonia severity of 50-60%. However, outcomes are variable and difficult to predict, and clinical trials report up to 25% of Nonresponders. Variability in electrode placement and inappropriate stimulation settings may account for much of this variability in outcome. In addition, improvement in dystonia is delayed, often days to weeks after a change in DBS therapy, complicating programming. Our group recently developed a computer model to predict optimal individualized stimulation settings in patients based on the outcome of a large cohort of of chronically treated patients. In-silico testing showed a 16.3% better mean group improvement with computer-assisted programming compared with physician-assisted programming and a dramatic reduction in non-responders (from 25% to 5%). In this prospective study, the computer model will be compared in a randomized, controlled, and double blinded setting against best clinical DBS programming. The primary outcome will be a responder analysis in which dystonia severity will be compared between conventional clinical and model-based programming will be compared.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2021

Completed
26 days until next milestone

First Posted

Study publicly available on registry

October 27, 2021

Completed
5 days until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 28, 2025

Status Verified

January 1, 2025

Enrollment Period

3.8 years

First QC Date

October 1, 2021

Last Update Submit

January 23, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • successful treatment with model predicted settings

    The primary efficacy endpoint is based on the blinded physician rating of dystonia severity reflected by Clinical Dystonia Rating Scales (BFMDRS or TWSTRS). The raters will be internationally recognized leading experts in the field of movement disorders that are not part of the study team or otherwise related to our center. For both interventions (best clinical settings and model predicted settings) we will calculate the symptom severity score after 4 weeks of continuous stimulation, expressed in percent of the pre-operative score. The primary endpoint is defined as "successful treatment with model predicted settings" (yes or no). The value is "yes" if the motor symptoms with model predicted settings are equal or better (tolerance 5%) to clinical settings.

    8 week follow-up

Secondary Outcomes (4)

  • quality of life SF-36 (Short Form-36)

    4 week and 8 week follow-up

  • quality of life CDQ24

    4 week and 8 week follow-up

  • calculated energy consumption

    Baseline visit

  • time for programming

    Baseline visit

Study Arms (2)

Computer

EXPERIMENTAL

Programming based on computer-guided assessment

Other: DBS programming

CLINICAL

ACTIVE COMPARATOR

Programming based on clinically-guided assessment

Other: DBS programming

Interventions

DBS readjustment based on COMPUTER or CLINICAL program

CLINICALComputer

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic deep brain stimulation (\> 1 year) in the internal globus pallidus in patients with isolated dystonia.
  • Deep brain stimulation settings and dystonia medication stable for \> 3 months.
  • Understanding about and consent to the study and signed informed consent form.

You may not qualify if:

  • Relevant comorbidities that might interfere with study endpoints (esp. palliative disease and severe neurologic or psychiatric comorbidities).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Neurology, University Hospital Würzburg

Würzburg, Bavaria, 97080, Germany

RECRUITING

Related Publications (1)

  • Lange F, Roothans J, Wichmann T, Gelbrich G, Roser C, Volkmann J, Reich M. DIPS (Dystonia Image-based Programming of Stimulation: a prospective, randomized, double-blind crossover trial). Neurol Res Pract. 2021 Dec 20;3(1):65. doi: 10.1186/s42466-021-00165-6.

MeSH Terms

Conditions

Dystonia

Condition Hierarchy (Ancestors)

DyskinesiasNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Martin Reich

    Department of Neurology - University Hosiptal Würzburg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Martin Reich, Dr.

CONTACT

Florian Lange, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2021

First Posted

October 27, 2021

Study Start

November 1, 2021

Primary Completion

September 1, 2025

Study Completion

December 1, 2025

Last Updated

January 28, 2025

Record last verified: 2025-01

Locations